Structural Formula (41d7651e B91a 4118 8719 Bf2f663d82a2 01)
Donepezil Hydrochloride Tablet, Film Coated
Product Images NDC 70518-1666
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Donepezil Hydrochloride (NDC 70518-1666). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (41d7651e B91a 4118 8719 Bf2f663d82a2 02)
Figure 2 (41d7651e B91a 4118 8719 Bf2f663d82a2 03)
Figure 3 (41d7651e B91a 4118 8719 Bf2f663d82a2 04)
This appears to be a table with three columns and seven rows. The first column shows the treatment given to patients, with either 0 (indicating a control group) or the drug Donepezil hydrochloride (presumably in various doses). The second column seems to be tracking the degree of improvement from baseline for each patient group, with categories ranging from "Markedly Improved" to "Markedly Worse." The third column lists the rating according to a measure called CIBIC-plus. Without further context, it is difficult to provide a more detailed description of the information in this table.*
Figure 4 (41d7651e B91a 4118 8719 Bf2f663d82a2 05)
The text describes the change in ADAS-cog score from baseline after weeks of drug treatment with Donepezil hydrochloride at doses of 5mg/day and 10mg/day, and a placebo. It indicates that there is a mean improvement in the ADAS-cog score. However, the specific extent of improvement is not mentioned. Therefore, the text provides limited information for evaluation.*
Figure 5 (41d7651e B91a 4118 8719 Bf2f663d82a2 06)
Figure 6 (41d7651e B91a 4118 8719 Bf2f663d82a2 07)
This is a table showing the percentage of patients receiving different dosages of Aricept and Placebo and the corresponding changes in CIBIC-plus rating - Markedly improved, Moderately improved, Minimally improved, No change, Minimaly worse, Moderately worse, Markedly worse.*
Figure 7 (41d7651e B91a 4118 8719 Bf2f663d82a2 08)
Figure 8 (41d7651e B91a 4118 8719 Bf2f663d82a2 09)
Figure 9 (41d7651e B91a 4118 8719 Bf2f663d82a2 10)
Figure 10 (41d7651e B91a 4118 8719 Bf2f663d82a2 11)
Remedy_label (Remedy Label)
Donepezil HCI is a prescription medicine. The NDC number is 70518-1666-00 and it is only available through a prescription. The package insert should be referred to for instructions on how to use it. This medication needs to be stored at 20-26°C (63-77°F) with temporary excursions permitted at 15-30°C (59-86°F) as per the USP. It is manufactured by Sclco located in Cranbury, NJ 08512 and repackaged by RemedyRepack Inc. Keep it out of the reach of children. Lot number and expiry dates are not mentioned.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
